Detalhe da pesquisa
1.
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System.
Mol Ther
; 28(9): 1974-1986, 2020 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32526203
2.
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia.
Mol Ther
; 25(8): 1933-1945, 2017 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28479045
3.
Donor-derived CD19-targeted T cells in allogeneic transplants.
Curr Opin Hematol
; 22(6): 497-502, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26390165
4.
Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway.
Blood
; 116(6): 935-44, 2010 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20448110
5.
Acute myeloid leukemia and novel biological treatments: monoclonal antibodies and cell-based gene-modified immune effectors.
Immunol Lett
; 155(1-2): 43-6, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24076117
6.
Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells.
Hum Immunol
; 70(12): 966-9, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19664675